REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Material Transfer & Cooperation Agreement

13 Jun 2022 07:30

RNS Number : 6077O
Quadrise Fuels International PLC
13 June 2022
 

13 June 2022

 

Quadrise Fuels International plc

("Quadrise," "QFI" or the "Company")

 

Material Transfer & Cooperation Agreement

Further to the announcement on 9 May 2022, Quadrise (AIM:QFI), the supplier of MSAR® and bioMSAR™ emulsion technology and fuels, providing innovative lower cost and lower carbon alternatives to fuel oil and biofuels, is pleased to announce it has signed a new Material Transfer & Cooperation Agreement (the "Agreement") with its client in Morocco (the "Client"). This Agreement supersedes the original agreement with the Client, announced on 29 November 2019.

Under the terms of the Agreement, Quadrise will manufacture trial quantities of MSAR® and bioMSAR™ for the purpose of an industrial demonstration test at one of the Client's sites. Quadrise will then provide the Client with a written report on the efficacy of using MSAR® and bioMSAR™. Provided the Client-specified deliverables regarding performance and product quality are met, the parties will enter into discussions for a potential commercial supply of MSAR® and/or bioMSAR™.

In parallel, Quadrise will also complete a technical and economic feasibility study for a potential additional industrial demonstration test at a second site of the Client. This study is close to completion, pending a final visit to the second site by the Quadrise team. This additional industrial demonstration test will be subject to future agreement, once confirmed.

The industrial demonstration test and feasibility study covered by this Agreement will occur concurrently, with completion expected in Q3 2022.

The Agreement is valid for one year unless mutually extended.

Jason Miles, CEO of Quadrise, commented:

"We are advancing all of our projects to progress them towards commerciality. We are pleased that we have renewed our agreement with this key Client in Morocco. We are confident that we will be able to demonstrate the economic and environmental benefits of using MSAR® and bioMSAR™ at the Client's industrial site, and look forward to expediting the project."

For further information, please refer to the Company's website at www.quadrisefuels.com or contact:

 

Quadrise Fuels International Plc

Andy Morrison, Chairman

Jason Miles, Chief Executive Officer

+44 (0)20 7031 7321

Nominated Adviser

Cenkos Securities plc

Ben Jeynes

+44 (0)20 7397 8900

Katy Birkin

 

Broker

Shore Capital Stockbrokers Limited

Toby Gibbs

+44 (0)20 7408 4090

Fiona Conroy

Public & Investor Relations

Vigo Consulting

Patrick D'Ancona

Charlie Neish

+44 (0)20 7390 0230

Notes to Editors

 

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology and fuels, providing innovative lower cost and lower carbon alternatives to fuel oil and biofuels in the global power generation, shipping, industrial and refining industries.

 

This announcement is inside information for the purposes of article 7 of Regulation 596/2014.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRBKNBBABKKFAD

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.